Ten years of riluzole use in a tertiary ALS clinic.
Andrew M GeronimoRichard M AlbertsonJames NotoZachary SimmonsPublished in: Muscle & nerve (2022)
A high rate of riluzole initiation and adherence was found in this sample. The most common reasons for dose modification were related to adverse effects, yet social-, economic-, and patient-related factors were also common. The characteristics of riluzole prescription and use have remained relatively unchanged in a single tertiary ALS center over the past 10 years.